Hormone therapy and cognitive function

Human Reproduction Update

Volumn 15, Issue 6, 2009, Pages 667-681

  Maki, Pauline M ^a   Sundermann, Erin ^a  

^a UNIVERSITY OF ILLINOIS AT CHICAGO   (United States)

Author keywords

Cognition; Estrogen; Hormone therapy; Memory; Menopause

Indexed keywords

ANDROGEN; CONJUGATED ESTROGEN; CONJUGATED ESTROGEN PLUS MEDROXYPROGESTERONE ACETATE; DIENOGEST; ESTRADIOL; ESTRADIOL BENZOATE; ESTRADIOL VALERATE; ESTROGEN; GESTAGEN; MEDROXYPROGESTERONE ACETATE; PIPERAZINE ESTRONE SULFATE; PLACEBO; PROGESTERONE; TESTOSTERONE ENANTATE;

AGE; ALZHEIMER DISEASE; CLINICAL TRIAL; COGNITION; COGNITIVE DEFECT; CONTROLLED CLINICAL TRIAL; DOSE RESPONSE; EARLY INTERVENTION; FRONTAL LOBE; HORMONAL THERAPY; HOT FLUSH; HUMAN; LOW DRUG DOSE; MEMORY DISORDER; MENOPAUSAL SYNDROME; NEUROIMAGING; NEUROPATHOLOGY; NONHUMAN; OUTCOME ASSESSMENT; POSTMENOPAUSE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; REVIEW; SYSTEMATIC REVIEW; VERBAL MEMORY; WOMEN'S HEALTH; WORKING MEMORY;

AGED; ESTROGENS; EXECUTIVE FUNCTION; FEMALE; HORMONE REPLACEMENT THERAPY; HUMANS; MEMORY; MIDDLE AGED; RANDOMIZED CONTROLLED TRIALS AS TOPIC;

EID: 70349996465     PISSN: 13554786     EISSN: 14602369     Source Type: Journal    
DOI: 10.1093/humupd/dmp022     Document Type: Review

References (130)

1. Adams MM, Morrison JH. Estrogen and the aging hippocampal synapse. Cereb Cortex 2003;13:1271-1275.
2. Albert MS, Kaplin E. Organic Implications of neuropsychological deficits in the elderly. In: Poon JLFLW, Cermak LS, Arenberg D, Thompson W (eds). New Directions in Memory and Aging: Proceedings of the George A. Talland Memorial Conference. Hillsdale, NJ: Erlbaum, 1980, 403-432.
3. Albert MS, Moss MB, Tanzi R, Jones K. Preclinical prediction of AD using neuropsychological tests. J Int Neuropsychol Soc 2001;7 631-639.
4. Almeida OP, Lautenschlager NT, Vasikaran S, Leedman P, Gelavis A, Flicker L. A 20-week randomized controlled trial of estradiol replacement therapy for women aged 70 years and older: Effect on mood, cognition and quality of life. Neurobiol Aging 2006;27 141-149.
5. Baddeley AD. Working Memory (trans.). New York: Oxford University Press, 1986.
6. Berman KF, Schmidt PJ, Rubinow DR, Danaceau MA, Van Horn JD, Esposito G, Ostrem JL, Weinberger DR. Modulation of cognition-specific cortical activity by gonadal steroids: A positron-emission tomography study in women. Proc Natl Acad Sci USA 1997;94:8836-8841.
7. Bethea CL, Pecins-Thompson M, Schutzer WE, Gundlah C, Lu ZN. Ovarian steroids and serotonin neural function. Mol Neurobiol 1998; 18 87-123.
8. Binder EF, Schechtman KB, Birge SJ, Williams DB, Kohrt WM. Effects of hormone replacement therapy on cognitive performance in elderly women. Maturitas 2001;38:137-146.
9. Bixo M, Backstrom T, Winblad B, Andersson A. Estradiol and testosterone in specific regions of the human female brain in different endocrine states. J Steroid Biochem Mol Biol 1995;55:297-303.
10. Blacker D, Lee H, Muzikansky A, Martin EC, Tanzi R, McArdle JJ, Moss M, Albert M. Neuropsychological measures in normal individuals that predict subsequent cognitive decline. Arch Neurol 2007;64:862-871.
11. Brett KM, Madans JH. Use of postmenopausal hormone replacement therapy: estimates from a nationally representative cohort study. Am J Epidemiol 1997;145:536-545.
12. Brett K, Chong Y. Hormone Replacement Therapy: Knowledge and Use in the United States. Hyattsville, Maryland: National Center for Health Statistics, 2001.
13. Cabeza R, Nyberg L. Neural bases of learning and memory: Functional neuroimaging evidence. Curr Opin Neurol 2000;13:415-421.
14. Craig MC, Fletcher PC, Daly EM, Rymer J, Cutter WJ, Brammer M, Giampietro V, Wickham H, Maki PM, Murphy DG. Gonadotropin hormone releasing hormone agonists alter prefrontal function during verbal encoding in young women. Psychoneuroendocrinology 2007; 32 1116-1127.
15. Craig MC, Fletcher PC, Daly EM, Rymer J, Brammer M, Giampietro V, Maki PM, Murphy DG. Reversibility of the effects of acute ovarian hormone suppression on verbal memory and prefrontal function in pre-menopausal women. Psychoneuroendocrinology 2008a.
16. Craig MC, Fletcher PC, Daly EM, Rymer J, Brammer M, Giampietro V, Stahl D, Maki PM, Murphy DG. The interactive effect of the cholinergic system and acute ovarian suppression on the brain: An fMRI study. Horm Behav 2008b.
17. Craik FIM, Jennings JM. Human Memory (trans.). Hillsdale, NJ: Erlbaum Associates, 1992.
18. D'Esposito M, Postle BR, Ballard D, Lease J. Maintenance versus manipulation of information held in working memory: An event-related fMRI study. Brain Cogn 1999;41:66-86.
19. Davis HP, Small SA, Stern Y, Mayeux R, Feldstein SN, Keller FR. Acquisition, recall, and forgetting of verbal information in long-term memory by young, middle-aged, and elderly individuals. Cortex 2003; 39:1063-1091.
20. Delis D, Kramer J, Kaplan E, Ober B. California Verbal Learning Test. Adult Version Manual, 2nd edn. (trans.) San Antonio, TX: Psychological Corporation, Harcourt-Brace, 2000.
21. Dempster FN. The rise and fall of the inhibitory mechanism: Toward a unified theory of cognitive development and aging. Dev Rev 1992; 12:45-75.
22. Ditkoff EC, Crary WG, Cristo M, Lobo RA. Estrogen improves psychological function in asymptomatic postmenopausal women. Obstet Gynecol 1991;78:991-995.
23. Duff SJ, Hampson E. A beneficial effect of estrogen on working memory in postmenopausal women taking hormone replacement therapy. Horm Behav 2000;38:262-276.
24. Duka T, Tasker R, McGowan JF. The effects of 3-week estrogen hormone replacement on cognition in elderly healthy females. Psychopharmacology (Berl) 2000;149:129-139.
25. Dumas J, Hancur-Bucci C, Naylor M, Sites C, Newhouse P. Estrogen treatment effects on anticholinergic-induced cognitive dysfunction in normal postmenopausal women. Neuropsychopharmacology 2006; 31 2065-2078.
26. Dumas J, Hancur-Bucci C, Naylor M, Sites C, Newhouse P. Estradiol interacts with the cholinergic system to affect verbal memory in postmenopausal women: Evidence for the critical period hypothesis. Horm Behav 2008;53:159-169.
27. Dunkin J, Rasgon N, Wagner-Steh K, David S, Altshuler L, Rapkin A. Reproductive events modify the effects of estrogen replacement therapy on cognition in healthy postmenopausal women. Psychoneuroendocrinology 2005;30:284-296.
28. Erickson KI, Colcombe SJ, Elavsky S, McAuley E, Korol DL, Scalf PE, Kramer AF. Interactive effects of fitness and hormone treatment on brain health in postmenopausal women. Neurobiol Aging 2007; 28 179-185.
29. Espeland M, Rapp S, Shumaker S, Brunner R, Manson J, Sherwin B, Hsia J, Margolis K, Hogan P, Wallace R et al. Conjugated equine estrogens and global cognitive function in postmenopausal women: Women's Health Initiative Memory Study. JAMA 2004;291:2959-2968.
30. Farr SA, Banks WA, Morley JE. Estradiol potentiates acetylcholine and glutamate-mediated post-trial memory processing in the hippocampus. Brain Res 2000;864:263-269.
31. Fedor-Freybergh P. The influence of oestrogens on the wellbeing and mental performance in climacteric and postmenopausal women. Acta Obstetrica Gynecologica Scandinavica 1977;64:1-91.
32. Gibbs RB. Estrogen replacement enhances acquisition of a spatial memory task and reduces deficits associated with hippocampal muscarinic receptor inhibition. Horm Behav 1999;36:222-233.
33. Gibbs RB. Long-term treatment with estrogen and progesterone enhances acquisition of a spatial memory task by ovariectomized aged rats. Neurobiol Aging 2000;21:107-116.
34. Gibbs RB, Gabor R. Estrogen and cognition: Applying preclinical findings to clinical perspectives. J Neurosci Res 2003;74:637-643.
35. Goebel JA, Birge SJ, Price SC, Hanson JM, Fishel DG. Estrogen replacement therapy and postural stability in the elderly. Am J Otol 19 95;16:470-474.
36. Grady D, Yaffe K, Kristof M, Lin F, Richards C, Barrett-Connor E. Effect of postmenopausal hormone therapy on cognitive function: The Heart and Estrogen/progestin Replacement Study. Am J Med 2002;113 543-548.
37. Grigorova M, Sherwin BB. No differences in performance on test of working memory and executive functioning between healthy elderly postmenopausal women using or not using hormone therapy. Climacteric 2006;9:181-194.
38. Grigorova M, Sherwin BB, Tulandi T. Effects of treatment with leuprolide acetate depot on working memory and executive functions in young premenopausal women. Psychoneuroendocrinology 2006;31: 935-947.
39. Hackman BW, Galbraith D. Replacement therapy and piperazine oestrone sulphate ('Harmogen') and its effect on memory. Curr Med Res Opin 1976;4:303-306.
40. Harman SM, Brinton EA, Cedars M, Lobo R, Manson JE, Merriam GR, Miller VM, Naftolin F, Santoro N. KEEPS: The Kronos Early Estrogen Prevention Study. Climacteric 2005;8:3-12.
41. Hays J, Ockene J, Brunner R, Kotchen J, Manson J, Patterson R, Aragaki A, Shumaker S, Brzyski R, LaCroix A et al. Effects of estrogen plus progestin on health-related quality of life. New Engl J Med 2003;348:348.
42. Henderson VW. Estrogen-containing hormone therapy and Alzheimer's disease risk: Understanding discrepant inferences from observational and experimental research. Neuroscience 2006;138:1031-1039.
43. Jacobs DM, Sano M, Dooneief G, Marder K, Bell KL, Stern Y. Neuropsychological detection and characterization of preclinical Alzheimer's disease. Neurology 1995;45:957-962.
44. Janowsky JS, Chavez B, Orwoll E. Sex steroids modify working memory. J Cogn Neurosci 2000;12:407-414.
45. Joffe H, Hall JE, Gruber S, Sarmiento IA, Cohen LS, Yurgelun-Todd D, Martin KA. Estrogen therapy selectively enhances prefrontal cognitive processes: A randomized, double-blind, placebo-controlled study with functional magnetic resonance imaging in perimenopausal and recently postmenopausal women. Menopause 2006;13:411-422.
46. Keenan PA, Ezzat WH, Ginsburg K, Moore GJ. Prefrontal cortex as the site of estrogen's effect on cognition. Psychoneuroendocrinology 2001; 26:577-590.
47. Kramer J, Delis D, Daniel M. Sex differences in verbal learning. J Clin Psychol 1988;44:907-915.
48. Kramer J, Yaffe K, Lengenfelder J, Delis D. Age and gender interactions on verbal memory performance. J Int Neuropsychol Soc 2003;9 97-102.
49. Krug R, Molle M, Dodt C, Fehm HL, Born J. Acute influences of estrogen and testosterone on divergent and convergent thinking in postmenopausal women. Neuropsychopharmacology 2003; 28:1538-1545.
50. Lamar M, Resnick SM, Zonderman AB. Longitudinal changes in verbal memory in older adults: Distinguishing the effects of age from repeat testing. Neurology 2003;60:82-86.
51. LeBlanc ES, Janowsky J, Chan BK, Nelson HD. Hormone replacement therapy and cognition: Systematic review and meta-analysis. JAMA 2001; 285:1489-1499.
52. LeBlanc ES, Neiss MB, Carello PE, Samuels MH, Janowsky JS. Hot flashes and estrogen therapy do not influence cognition in early menopausal women. Menopause 2007;14:191-202.
53. Linn RT, Wolf PA, Bachman DL, Knoefel JE, Cobb JL, Belanger AJ, Kaplan EF, D'Agostino RB. The 'preclinical phase' of probable Alzheimer's disease. A 13-year prospective study of the Framingham cohort. Arch Neurol 1995;52:485-490.
54. Linzmayer L, Semlitsch HV, Saletu B, Bock G, Saletu-Zyhlarz G, Zoghlami A, Gruber D, Metka M, Huber J, Oettel M et al. Double-blind, placebo-controlled psychometric studies on the effects of a combined estrogen-progestin regimen versus estrogen alone on performance, mood and personality of menopausal syndrome patients. Arzneimittelforschung 2001;51:238-245.
55. Maki PM. Methodological pitfalls in the study of estrogen on cognition and brain function. In: Genazanni A (ed). Hormone Replacement Therapy and Neurological Function. Boca Raton, FL: CRC Press, 2003.
56. Maki PM. Hormone therapy and cognitive function: Is there a critical period for benefit? Neuroscience 2006;138:1027-1030.
57. Maki PM, Resnick SM. Longitudinal effects of estrogen replacement therapy on PET cerebral blood flow and cognition. Neurobiol Aging 2000;21:373-383.
58. Maki PM, Resnick SM. Effects of estrogen on patterns of brain activity at rest and during cognitive activity: A review of neuroimaging studies. Neuroimage 2001;14:789-801.
59. Maki P, Zonderman A, Resnick S. Enhanced verbal memory in nondemented elderly women receiving hormone-replacement therapy. Am J Psychiatry 2001;158:227-233.
60. Maki PM, Gast MJ, Vieweg AJ, Burriss SW, Yaffe K. Hormone therapy in menopausal women with cognitive complaints: A randomized, double-blind trial. Neurology 2007;69:1322-1330.
61. Maki PM, Drogos LL, Rubin LH, Banuvar S, Shulman LP, Geller SE. Objective hot flashes are negatively related to verbal memory performance in midlife women. Menopause 2008;15:848-856.
62. Manoach DS, Greve DN, Lindgren KA, Dale AM. Identifying regional activity associated with temporally separated components of working memory using event-related functional MRI. Neuroimage 2003; 20 1670-1684.
63. Markowska AL, Savonenko AV. Effectiveness of estrogen replacement in restoration of cognitive function after long-term estrogen withdrawal in aging rats. J Neurosci 2002;22:10985-10995.
64. McEwen BS, Woolley CS. Estradiol and progesterone regulate neuronal structure and synaptic connectivity in adult as well as developing brain. Exp Gerontol 1994;29:431-436.
65. McEwen BS, Alves SE, Bulloch K, Weiland NG. Ovarian steroids and the brain: Implications for cognition and aging. Neurology 1997;48 S8-S15.
66. Miller BL, Cummings JL. The Frontal Lobes: Functions and Disorders (trans.). New York: Guilford Press, 1999.
67. Mitchell E, Woods N. Midlife women's attributions about perceived memory changes: Observations from the Seattle Midlife Women's Health Study. J Women's Health Gender Based Med 2001;10: 351-362.
68. Morris JC, Heyman A, Mohs RC, Hughes JP, van Belle G, Fillenbaum G, Mellits ED, Clark C. The Consortium to Establish a Registry for Alzheimer's Disease (CERAD). Part I. Clinical and neuropsychological assessment of Alzheimer's disease. Neurology 1989;39 1159-1165.
69. Moscovitch MW, Winocur G. The neuropsychology of memory and aging. In: Craik TASFIM (ed). The Handbook of Aging and Cognition. Hillsdale, NJ: Lawrence Erlbaum Associates, Inc., 1992, 315-372.
70. Nilsen J, Brinton RD. Impact of progestins on estradiol-potentiation of the glutamate calcium response. Neuroreport 2002a;13:825-830.
71. Nilsen J, Brinton RD. Impact of progestins on estrogen-induced neuroprotection: Synergy by progesterone and 19-norprogesterone and antagonism by medroxyprogesterone acetate. Endocrinology 2002b; 143:205-212.
72. Nilsen J, Brinton RD. Divergent impact of progesterone and medroxyprogesterone acetate (Provera) on nuclear mitogen-activated protein kinase signaling. Proc Natl Acad Sci USA 2003;100 10506-10511.
73. Norbury R, Travis MJ, Erlandsson K, Waddington W, Ell PJ, Murphy DG. Estrogen therapy and brain muscarinic receptor density in healthy females: A SPET study. Horm Behav 2007;51:249-257.
74. Nyberg L, McIntosh AR, Cabeza R, Habib R, Houle S, Tulving E. General and specific brain regions involved in encoding and retrieval of events: what, where, and when. Proc Natl Acad Sci USA 1996;93 11280-11285.
75. Pan Y, Anthony M, Clarkson TB. Effect of estradiol and soy phytoestrogens on choline acetyltransferase and nerve growth factor mRNAs in the frontal cortex and hippocampus of female rats. Proc Soc Exp Biol Med 1999;221:118-125.
76. Pefanco MA, Kenny AM, Kaplan RF, Kuchel G, Walsh S, Kleppinger A, Prestwood K. The effect of 3-year treatment with 0.25 mg/day of micronized 17beta-estradiol on cognitive function in older postmenopausal women. J Am Geriatr Soc 2007;55:426-431.
77. Phillips SM, Sherwin BB. Effects of estrogen on memory function in surgically menopausal women. Psychoneuroendocrinology 1992; 17 485-495.
78. Polo-Kantola P, Portin R, Polo O, Helenius H, Irjala K, Erkkola R. The effect of short-term estrogen replacement therapy on cognition: A randomized, double-blind, cross-over trial in postmenopausal women. Obstet Gynecol 1998;91:459-466.
79. Postle BR, Berger JS, D'Esposito M. Functional neuroanatomical double dissociation of mnemonic and executive control processes contributing to working memory performance. Proc Natl Acad Sci USA 1999;96 12959-12964.
80. Ramage A, Bayles K, Helm-Estabrooks N, Cruz R. Frequency of perseveration in normal subjects. Brain Lang 1999;66:329-340.
81. Rapp PR, Morrison JH, Roberts JA. Cyclic estrogen replacement improves cognitive function in aged ovariectomized rhesus monkeys. J Neurosci 2003a;23:5708-5714.
82. Rapp SR, Legault C, Thal L, Wallace RB, Ockene JK, Hendrix SL, Jones BN 3rd, Assaf AR, Jackson RD, Kotchen JM et al. Effect of estrogen plus progestin on global cognitive function in postmenopausal women: The Women's Health Initiative Memory Study: A randomized controlled trial. JAMA 2003b;289:2651-2662.
83. Resnick SM, Henderson VW. Hormone therapy and risk of Alzheimer disease: a critical time. JAMA 2002;288:288.
84. Resnick SM, Maki PM, Golski S, Kraut MA, Zonderman AB. Estrogen effects on PET cerebral blood flow and neuropsychological performance. Horm Behav 1998;34:171-184.
85. Resnick SM, Maki PM, Rapp SR, Espeland MA, Brunner R, Coker LH, Granek IA, Hogan P, Ockene JK, Shumaker SA. Effects of combination estrogen plus progestin hormone treatment on cognition and affect. J Clin Endocrinol Metab 2006
86. Rocca WA, Bower JH, Maraganore DM, Ahlskog JE, Grossardt BR, de Andrade M, Melton LJ 3rd. Increased risk of cognitive impairment or dementia in women who underwent oophorectomy before menopause. Neurology 2007;69:1074-1083.
87. Rossouw JE, Prentice RL, Manson JE, Wu L, Barad D, Barnabei VM, Ko M, LaCroix AZ, Margolis KL, Stefanick ML. Postmenopausal hormone therapy and risk of cardiovascular disease by age and years since menopause. JAMA 2007;297:1465-1477.
88. Saletu B, Anderer P, Gruber D, Metka M, Huber J, Saletu-Zyhlarz GM. Hormone replacement therapy and vigilance: Double-blind, placebo-controlled EEG-mapping studies with an estrogen-progestogen combination (Climodien, Lafamme) versus estrogen alone in menopausal syndrome patients. Maturitas 2002;43: 165-181.
89. Sandberg G, Stewart W, Smialek J, Troncoso JC. The prevalence of the neuropathological lesions of Alzheimer's disease is independent of race and gender. Neurobiol Aging 2001;22:169-175.
90. Sano M, Bell K, Jacobs D. Cognitive effects of estrogens in women with cardiovascular disease: What we do not know. Am J Med 2002; 113 612-613.
91. Saxton J, Lopez OL, Ratcliff G, Dulberg C, Fried LP, Carlson MC, Newman AB, Kuller L. Preclinical Alzheimer disease: Neuropsychological test performance 1.5 to 8 years prior to onset. Neurology 2004;63 2341-2347.
92. Schacter DL, Wagner AD. Medial temporal lobe activations in fMRI and PET studies of episodic encoding and retrieval. Hippocampus 1999; 9 7-24.
93. Schacter DL, Curran T, Reiman EM, Chen K, Bandy DJ, Frost JT. Medial temporal lobe activation during episodic encoding and retrieval: A PET study. Hippocampus 1999;9:575-581.
94. Schiff R, Bulpitt CJ, Wesnes KA, Rajkumar C. Short-term transdermal estradiol therapy, cognition and depressive symptoms in healthy older women. A randomised placebo controlled pilot cross-over study. Psychoneuroendocrinology 2005;30:309-315.
95. Shaywitz SE, Shaywitz BA, Pugh KR, Fulbright RK, Skudlarski P, Mencl WE, Constable RT, Naftolin F, Palter SF, Marchione KE et al. Effect of estrogen on brain activation patterns in postmenopausal women during working memory tasks. JAMA 1999;281:1197-1202.
96. Shaywitz SE, Naftolin F, Zelterman D, Marchione KE, Holahan JM, Palter SF, Shaywitz BA. Better oral reading and short-term memory in midlife, postmenopausal women taking estrogen. Menopause 2003; 10 420-426.
97. Sherwin BB. Affective changes with estrogen and androgen replacement therapy in surgically menopausal women. J Affect Disord 1988a; 14:177-187.
98. Sherwin BB. Estrogen and/or androgen replacement therapy and cognitive functioning in surgically menopausal women. Psychoneuroendocrinology 1988b;13:345-357.
99. Sherwin BB, Tulandi T. 'Add-back' estrogen reverses cognitive deficits induced by a gonadotropin-releasing hormone agonist in women with leiomyomata uteri. J Clin Endocrinol Metab 1996;81:2545-2549.
100. Shumaker SA, Reboussin BA, Espeland MA, Rapp SR, McBee WL, Dailey M, Bowen D, Terrell T, Jones BN. The Women's Health Initiative Memory Study (WHIMS): A trial of the effect of estrogen therapy in preventing and slowing the progression of dementia. Control Clin Trials 1998; 19:604-621.
101. Shumaker S, Legault C, Rapp S, Thal L, Wallace R, Ockene J, Hendrix S, Jones B, Assaf A, Jackson R et al. Estrogen plus progestin and the incidence of dementia and mild cognitive impairment in postmenopausal women: The Women's Health Initiative MAmory Study: a randomized controlled trial. JAMA 2003;289:2651-2662.
102. Shumaker S, Legault C, Kuller L, Rapp S, Thal L, Lane D, Fillit H, Stefanick M, Hendrix S, Lewis C et al. Conjugated equine estrogens and incidence of probable dementia and mild cognitive impairment in postmenopausal women: Women's Health Initiative Memory Study. JAMA 2004;291:2947-2958.
103. Singh M, Meyer EM, Millard WJ, Simpkins JW. Ovarian steroid deprivation results in reversible learning impairment and compromised cholinergic function in female Sprague-Dawley rats. Brain Res 1994;644 305-312.
104. Stuss DT, Craik FI, Sayer L, Franchi D, Alexander MP. Comparison of older people and patients with frontal lesions: Evidence from world list learning. Psychol Aging 1996;11:387-395.
105. Tabert MH, Manly JJ, Liu X, Pelton GH, Rosenblum S, Jacobs M, Zamora D, Goodkind M, Bell K, Stern Y et al. Neuropsychological prediction of conversion to Alzheimer disease in patients with mild cognitive impairment. Arch Gen Psychiatry 2006;63:916-924.
106. Tang M-X, Jacobs D, Stern Y, Marder K, Schofield P, Gurland B, Andrews H, Mayeux R. Effect of oestrogen during menopause on risk and age at onset of Alzheimer's disease. Lancet 1996;348:429-432.
107. Tang Y, Janssen WG, Hao J, Roberts JA, McKay H, Lasley B, Allen PB, Greengard P, Rapp PR, Kordower JH et al. Estrogen replacement increases spinophilin-immunoreactive spine number in the prefrontal cortex of female rhesus monkeys. Cereb Cortex 2004;14 215-223.
108. Tian J, Bucks RS, Haworth J, Wilcock G. Neuropsychological prediction of conversion to dementia from questionable dementia: Statistically significant but not yet clinically useful. J Neurol Neurosurg Psychiatr 2003;74:433-438.
109. Tierney MC, Yao C, Kiss A, McDowell I. Neuropsychological tests accurately predict incident Alzheimer disease after 5 and 10 years. Neurology 2005;64:1853-1859.
110. Toran-Allerand CD, Miranda RC, Bentham WDL, Sohrabji F, Brown TJ, Hochberg RB, MacLusky NJ. Estrogen receptors colocalize with low-affinity nerve growth factor receptors in cholinergic neurons of the basal forebrain. Proc Natl Acad Sci 1992;89:4668-4672.
111. van de Weijer PH. Risks of hormone therapy in the 50-59 year age group. Maturitas 2008;60:59-64.
112. Vanhulle G, Demol R. A double-blind study into the influence of estriol on a number of psychological tests in post-menopausal women. In: Van Keep PA, Greenblatt RB, Albeaux-Fernet M (eds). Consensus on the Menopause Research. London: MTP Press, 1976, 94-99.
113. Veltman DJ, Rombouts SA, Dolan RJ. Maintenance versus manipulation in verbal working memory revisited: An fMRI study. Neuroimage 2003; 18:247-256.
114. Viscoli CM, Brass LM, Kernan WN, Sarrel PM, Suissa S, Horwitz RI. Estrogen therapy and risk of cognitive decline: Results from the Women's Estrogen for Stroke Trial (WEST). Am J Obstet Gynecol 2005;192 387-393.
115. Wallace M, Luine V, Arellanos A, Frankfurt M. Ovariectomized rats show decreased recognition memory and spine density in the hippocampus and prefrontal cortex. Brain Res 2006;1126:176-182.
116. Wechsler D. Manual for the Wechsler Memory Scale-Revised (trans.). San Antonio, TX: Psychological Corporation, 1987.
117. Wegesin DJ, Stern Y. Effects of hormone replacement therapy and aging on cognition: Evidence for executive dysfunction. Neuropsychol Dev Cogn B Aging Neuropsychol Cogn 2007;14:301-328.
118. West RL. An application of prefrontal cortex function theory to cognitive aging. Psychol Bull 1996;120:272-292.
119. Wheeler MA, Stuss DT, Tulving E. Frontal lobe damage produces episodic memory impairment. J Int Neuropsychol Soc 1995;1:525-536.
120. Wolf OT, Kudielka BM, Hellhammer DH, Torber S, McEwen BS, Kirschbaum C. Two weeks of transdermal estradiol treatment in postmenopausal elderly women and its effect on memory and mood: Verbal memory changes are associated with the treatment induced estradiol levels. Psychoneuroendocrinology 1999;24:727-741.
121. Woods NF, Mitchell ES, Adams C. Memory functioning among midlife women: observations from the Seattle Midlife Women's Health Study. Menopause 2000;7:257-265.
122. Woolley CS. Acute effects of estrogen on neuronal physiology. Annu Rev Pharmacol Toxicol 2007;47:657-680.
123. Woolley CS, McEwen BS. Estradiol regulates hippocampal dendritic spine density via an N-methyl-D-aspartate receptor-dependent mechanism. J Neurosci 1994;14:7680-7687.
124. Woolley CS, Gould E, Frankfurt M, McEwen BS. Naturally occurring fluctuation in dendritic spine density on adult hippocampal pyramidal neurons. J Neurosci 1990;10:4035-4039.
125. Woolley CS, Wenzel HJ, Schwartzkroin PA. Estradiol increases the frequency of multiple synapse boutons in the hippocampal CA1 region of the adult female rat. J Comp Neurol 1996;373:108-117.
126. Wysowski DK, Golden L, Burke L. Use of menopausal estrogens and medroxyprogesterone in the United States, 1982-1992. Obstet Gynecol 1995;85:6-10.
127. Yaffe K, Sawaya G, Lieberburg I, Grady D. Estrogen therapy in postmenopausal women: Effects on cognitive function and dementia. JAMA 1998;279:688-695.
128. Yaffe K, Vittinghoff E, Ensrud KE, Johnson KC, Diem S, Hanes V, Grady D. Effects of ultra-low-dose transdermal estradiol on cognition and health-related quality of life. Arch Neurol 2006;63:945-950.
129. Zandi PP, Carlson MC, Plassman BL, Welsh-Bohmer KA, Mayer LS, Steffens DC, Brietner JCS. Hormone replacement therapy and incidence of Alzheimer's disease in older women: The Cache County Study. JAMA 2002;288:2123-2129.
130. Zelinski EM, Burnight KP. Sixteen-year longitudinal and time lag changes in memory and cognition in older adults. Psychol Aging 1997;12 503-513.